Copyright
©The Author(s) 2021.
World J Clin Cases. Apr 26, 2021; 9(12): 2890-2898
Published online Apr 26, 2021. doi: 10.12998/wjcc.v9.i12.2890
Published online Apr 26, 2021. doi: 10.12998/wjcc.v9.i12.2890
Hospital day | Reference range | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 | Day 8 | Day 9 | Day 10 | Day 11 | Day 12 | Day 13 |
Feb 25, 2020 | Feb 26, 2020 | Feb 27, 2020 | Feb 28, 2020 | Feb 29, 2020 | Mar 1, 2020 | Mar 2, 2020 | Mar 3, 2020 | Mar 4, 2020 | Mar 5, 2020 | Mar 6, 2020 | Mar 7, 2020 | ||
Nucleic acid testing | P | P | P | N | N | ||||||||
Antibody | IgG+ | IgG+ | Detection IgM+ | - | IgM+ | ||||||||
IL6 in pg/mL | 0-10 | - | 24.63↑ | 66.21↑ | 21.47↑ | - | |||||||
BNP in pg/mL | 0-100 | 78.8 | 135.4↑ | 242.1↑ | |||||||||
Albumin in g/L | 35-52 | 29.4 | 29.1 | 33.4 | 35 | 31.6 | 34.7 | 35.7 | |||||
Blood clean | 1-2.4 | 0.95↓ | 0.8↓ | 0.95 | 0.91 | 0.93 | 1.05 | 1.08 | |||||
Globulin, A/GGlutamic pyruvic | 0-55 | 49.3 | 34.2 | 17.4 | 20.7 | 16.4 | 13.7 | 17.3 | |||||
Transaminase, ALT in U/L, GGT in U/L | 12-64 | 96↑ | 75↑ | 57 | 52 | 42 | 35 | 34 | |||||
TBA in μmol/L | 0-9.67 | 4 | 2.5 | 19.3 | 14.5 | 29.7 | 42.8 | 11.2 | |||||
CRE in μmol/L | 64-104 | 73.1 | 62↓ | 50.8↓ | 55.1↓ | 53.2↓ | 42.6↓ | 48.4 | |||||
UA in μmol/L | 210-420 | 293 | 346 | 246 | 256 | 241 | 118↓ | 116 | |||||
hs-cTn in pg/mL | 0-34.2 | 19 | |||||||||||
MYO in ng/mL | 0-106 | 498.7↑ | |||||||||||
CK-MB in ng/mL | 0-3.1 | 11.1 ↑ | |||||||||||
D-Dimer in mg/L | 0-0.55 | 3.17 | 4.38 | ||||||||||
LYM, % | 20-50 | 12.1↓ | 14.9↓ | 12.8↓ | 14.4 | ||||||||
LYM, × 109/L | 1.1-3.2 | 0.63↓ | 0.69↓ | 0.84↓ | 1.08 | ||||||||
RBC, × 1012/L | 4.3-5.8 | 3.29↓ | 3.35↓ | 3.27↓ | 3.22 | ||||||||
HGB in g/L | 130-175 | 100↓ | 100↓ | 97↓ | 95 | ||||||||
Red blood cell specific volume, HCT, % | 40-50 | 29.3↓ | 29.7↓ | 29.3↓ | 28.7 | ||||||||
hs-CRP in mg/L | 0-10 | 108.43↑ | 49.18↑ | 27.03 | 24.97 | ||||||||
tHb in g/L | 117-174 | 70↓ | 94↓ | 115 | |||||||||
Carbon monoxide | 0.5-1.5 | 2.2↑ | 1.3 | 1.5 | |||||||||
COHb, % un-ionized HHb, % | 0--5 | -0.4 | 0.6 | 0.2 | |||||||||
Glucose in mmol/L | 3.6-5.2 | 10.9↑ | 6.2↑ | 8.1 | |||||||||
Base excess of blood in mmol/L | -2-3 | -5.1↓ | 4.6↑ | 4.1 | |||||||||
Beecf in mmol/L | -2-3 | -5.6↓ | 5↑ | 4.7 |
- Citation: Liu B, Ren KK, Wang N, Xu XP, Wu J. Timing of convalescent plasma therapy-tips from curing a 100-year-old COVID-19 patient using convalescent plasma treatment: A case report . World J Clin Cases 2021; 9(12): 2890-2898
- URL: https://www.wjgnet.com/2307-8960/full/v9/i12/2890.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i12.2890